Psychosocial Adjustment During the Post-Radiation Treatment Transition
18 Years
N/A
Both
Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
Trial Information
Psychosocial Adjustment During the Post-Radiation Treatment Transition
OBJECTIVES:
- To describe psychosocial adjustment after radiotherapy in patients with stage I, II, or
III breast, colorectal, lung, or prostate cancer.
- To determine if cognitive appraisal of health predicts psychosocial adjustment of these
patients after radiotherapy.
- To examine whether social support moderates the relationship between cognitive
appraisal of health and psychosocial adjustment of these patients after radiotherapy.
- To examine whether self-efficacy for coping with cancer moderates the relationship
between cognitive appraisal of health and psychosocial adjustment of these patients
after radiotherapy.
- To measure the effect of symptom distress, uncertainty, medical factors, and personal
factors on cognitive appraisal of health of these patients before ending radiotherapy.
OUTLINE: Two weeks before completing planned radiotherapy, patients undergo assessment of
stress appraisal and other factors predictive of post-radiotherapy psychosocial adjustment.
Patients complete psychosocial assessments, including measures of patient perceptions of
their illness (i.e., cognitive appraisal) and of the factors influencing their perceptions
(i.e., uncertainty by the Mishel Uncertainty in Illness Scale-Community Form; symptom
distress by the Memorial Symptom Assessment Scale Short Form; and comorbidity by the
Charlson Comorbidity Index). Measures of patient social support and self-efficacy for coping
are also assessed. At 1 month after completion of radiotherapy, patients undergo repeat
assessment of stress appraisal and psychosocial adjustment.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Diagnosis of breast, colorectal, lung, or prostate cancer
- Stage I, II, or III disease
- Nonmetastatic disease
- Undergoing first course of curative radiotherapy, as indicated in the medical record
- Receiving treatment as an outpatient
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Menopausal status not specified
- Able to receive treatment as an outpatient
- Lives in northeastern Ohio
- Cognitively intact, as evidenced by orientation to person, place, and time
- Has a telephone
- No hearing impairment (must be able to hear instructions)
- No malignancy expected to require surgery or chemotherapy ≤ 2 months after treatment
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior radiotherapy for another type of cancer
- No concurrent or planned chemotherapy or surgery for at least 2 months after
radiotherapy
- No concurrent treatment for recurrent cancer
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Relationship between stress appraisal (as assessed by CAHS at baseline) and psychosocial adjustment (as assessed by PAIS-SR at 1 month after radiotherapy)
Outcome Time Frame:
one month after radiotherapy
Safety Issue:
No
Principal Investigator
Barbara Daly, PhD, RN
Investigator Role:
Principal Investigator
Investigator Affiliation:
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
CASE3Z08
NCT ID:
NCT00905086
Start Date:
August 2008
Completion Date:
May 2009
Related Keywords:
- Breast Cancer
- Cognitive/Functional Effects
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Psychosocial Effects of Cancer and Its Treatment
- cognitive/functional effects
- psychosocial effects of cancer and its treatment
- stage I breast cancer
- stage II breast cancer
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage I colon cancer
- stage II colon cancer
- stage III colon cancer
- stage I rectal cancer
- stage II rectal cancer
- stage III rectal cancer
- stage I non-small cell lung cancer
- stage II non-small cell lung cancer
- stage IIIA non-small cell lung cancer
- stage IIIB non-small cell lung cancer
- stage I prostate cancer
- stage II prostate cancer
- stage III prostate cancer
- extensive stage small cell lung cancer
- limited stage small cell lung cancer
- Breast Neoplasms
- Colorectal Neoplasms
- Lung Neoplasms
- Prostatic Neoplasms
Name | Location |
|---|---|
| Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center | Cleveland, Ohio 44106-5065 |
